RNA
Atrium Therapeutics, Inc. Common StockNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$209.54M
P/E Ratio
—
EPS
$-5.02
Beta
0.93
52W High
$16.77
52W Low
$11.40
50-Day MA
$13.11
200-Day MA
$13.40
Dividend Yield
—
Profit Margin
-160.00%
Forward P/E
—
PEG Ratio
0.00
About Atrium Therapeutics, Inc. Common Stock
Avidity Biosciences, Inc., a biopharmaceutical company, is dedicated to the development of oligonucleotide-based therapies. The company is headquartered in La Jolla, California.
Fundamentals
| Revenue (TTM) | $36.68M |
| Gross Profit (TTM) | $-12.07M |
| EBITDA | $-59.04M |
| Operating Margin | -88.00% |
| Return on Equity | -44.00% |
| Return on Assets | -399.30% |
| Revenue/Share (TTM) | $2.14 |
| Book Value | $13.69 |
| Price-to-Book | 0.91 |
| Price-to-Sales (TTM) | 5.71 |
| EV/Revenue | 491.01 |
| EV/EBITDA | -5.72 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1148.00% |
| Shares Outstanding | $17.11M |
| Float | $15.76M |
| % Insiders | 4.27% |
| % Institutions | 87.68% |
Historical Volatility
HV 10-Day
48.18%
HV 20-Day
38.59%
HV 30-Day
37.95%
HV 60-Day
42.98%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($25.00 target)
1
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026